Structural, Functional, and Molecular Imaging of Autism Spectrum Disorder

• Published in: Neuroscience bulletin Vol. 37; no. 7; pp. 1051 - 1071
• Main Authors: Li, Xiaoyi, Zhang, Kai, He, Xiao, Zhou, Jinyun, Jin, Chentao, Shen, Lesang, Gao, Yuanxue, Tian, Mei, Zhang, Hong
• Format: Journal Article
• Language: English
• Published: Singapore Springer Singapore 01.07.2021; Springer
• Subjects: Anatomy; Anesthesiology; Autism; Biomedical and Life Sciences; Biomedicine; Human Physiology; Neural circuitry; Neural networks; Neurology; Neurophysiology; Neurosciences; Pain Medicine; PET imaging; Review; SPECT imaging; Molecular imaging; Functional connectivity; Magnetic resonance imaging; Serotonin; Oxytocin; Positron emission tomography; Autism spectrum disorder
• ISSN: 1673-7067; 1995-8218
• DOI: 10.1007/s12264-021-00673-0

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder associated with both genetic and environmental risks. Neuroimaging approaches have been widely employed to parse the neurophysiological mechanisms underlying ASD, and provide critical insights into the anatomical, functional, and neurochemical changes. We reviewed recent advances in neuroimaging studies that focused on ASD by using magnetic resonance imaging (MRI), positron emission tomography (PET), or single-positron emission tomography (SPECT). Longitudinal structural MRI has delineated an abnormal developmental trajectory of ASD that is associated with cascading neurobiological processes, and functional MRI has pointed to disrupted functional neural networks. Meanwhile, PET and SPECT imaging have revealed that metabolic and neurotransmitter abnormalities may contribute to shaping the aberrant neural circuits of ASD. Future large-scale, multi-center, multimodal investigations are essential to elucidate the neurophysiological underpinnings of ASD, and facilitate the development of novel diagnostic biomarkers and better-targeted therapy.